Terms: = Endocrine gland cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
727 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201).
Imai H; Sakamoto Y; Takahashi S; Shibata H; Sato A; Otsuka K; Amagai K; Takahashi M; Yamaguchi T; Ishioka C
BMC Cancer; 2024 Feb; 24(1):262. PubMed ID: 38402399
[TBL] [Abstract] [Full Text] [Related]
3. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial.
Zhang D; Benedikt Westphalen C; Quante M; Waldschmidt DT; Held S; Kütting F; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Boeck S; Heinemann V; Probst V
Eur J Cancer; 2024 Apr; 201():113926. PubMed ID: 38401449
[TBL] [Abstract] [Full Text] [Related]
4. Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness.
Kardoust Parizi M; Margulis V; Bagrodia A; Bekku K; Klemm J; Matsukawa A; Alimohammadi A; Motlagh RS; Mostafaei H; Laukhtina E; Shariat SF
Urol Oncol; 2024 Apr; 42(4):102-109. PubMed ID: 38360519
[TBL] [Abstract] [Full Text] [Related]
5. Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
Grunt TW; Wagner R; Ries A; Berghoff AS; Preusser M; Grusch M; Valent P
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214315
[TBL] [Abstract] [Full Text] [Related]
6. Chimeric Antigen Receptor T Cell Therapy for Pancreatic cancer: A Review of Current Evidence.
Czaplicka A; Lachota M; Pączek L; Zagożdżon R; Kaleta B
Cells; 2024 Jan; 13(1):. PubMed ID: 38201305
[TBL] [Abstract] [Full Text] [Related]
7. Ovarian cancer treatment and natural killer cell-based immunotherapy.
Fan Z; Han D; Fan X; Zhao L
Front Immunol; 2023; 14():1308143. PubMed ID: 38187402
[TBL] [Abstract] [Full Text] [Related]
8. NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through fas/cd95 Inhibition.
Crescenzi E; Mellone S; Gragnano G; Iaccarino A; Leonardi A; Pacifico F
Endocrinology; 2023 Dec; 165(2):. PubMed ID: 38091978
[TBL] [Abstract] [Full Text] [Related]
9. Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer.
Chauhan S; Langstraat CL; Fought AJ; McGree ME; Cliby WA; Kumar A
Gynecol Oncol; 2024 Jan; 180():126-131. PubMed ID: 38091771
[TBL] [Abstract] [Full Text] [Related]
10. NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas.
Albuquerque Pinto Rebello I; Loures de Oliveira V; Abbud LFH; Aprígio Camargos Ferreira T; Vidal APA; de Fátima Dos Santos Teixeira P
Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 38029301
[TBL] [Abstract] [Full Text] [Related]
11. Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer.
Yu HY; Yang L; Liu YC; Yu AJ
PeerJ; 2023; 11():e16308. PubMed ID: 38025760
[TBL] [Abstract] [Full Text] [Related]
12. Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian cancer Cells and Their Therapeutic Opportunities.
Szyposzynska A; Bielawska-Pohl A; Murawski M; Sozanski R; Chodaczek G; Klimczak A
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958844
[TBL] [Abstract] [Full Text] [Related]
13. Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells.
Szymoński K; Skirlińska-Nosek K; Lipiec E; Sofińska K; Czaja M; Wilkosz N; Krupa M; Wanat F; Ulatowska-Białas M; Adamek D
Anal Bioanal Chem; 2023 Dec; 415(29-30):7281-7295. PubMed ID: 37906289
[TBL] [Abstract] [Full Text] [Related]
14. Strong apoptotic response of testis tumor cells following cisplatin treatment.
Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
[TBL] [Abstract] [Full Text] [Related]
15. [Related factors of high-volume lymph node metastasis in multifocal papillary thyroid carcinoma].
Hu CF; Zhang T; Wei PY; Cao HJ; Han ZJ
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3199-3203. PubMed ID: 37879874
[No Abstract] [Full Text] [Related]
16. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
Tassi E; Bergamini A; Wignall J; Sant'Angelo M; Brunetto E; Balestrieri C; Redegalli M; Potenza A; Abbati D; Manfredi F; Cangi MG; Magliacane G; Scalisi F; Ruggiero E; Maffia MC; Trippitelli F; Rabaiotti E; Cioffi R; Bocciolone L; Candotti G; Candiani M; Taccagni G; Schultes B; Doglioni C; Mangili G; Bonini C
Front Immunol; 2023; 14():1212444. PubMed ID: 37868997
[TBL] [Abstract] [Full Text] [Related]
17. Characterizing the regulatory fas (cd95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.
Mondal T; Gaur H; Wamba BEN; Michalak AG; Stout C; Watson MR; Aleixo SL; Singh A; Condello S; Faller R; Leiserowitz GS; Bhatnagar S; Tushir-Singh J
Cell Death Differ; 2023 Nov; 30(11):2408-2431. PubMed ID: 37838774
[TBL] [Abstract] [Full Text] [Related]
18. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract] [Full Text] [Related]
19. Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system.
Xu Y; Liu W; Long Z; Wang L; Zhou M; Yin P
BMC Cancer; 2023 Sep; 23(1):893. PubMed ID: 37735368
[TBL] [Abstract] [Full Text] [Related]
20. KRAS
Yeh C; Park W; Yaeger R
Dev Cell; 2023 Sep; 58(17):1515-1516. PubMed ID: 37699334
[TBL] [Abstract] [Full Text] [Related]
[Next]
